Effectiveness and safety of early add‐on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: <scp>BRIV</scp> ‐add study
This study evaluated how effective and safe brivaracetam (BRV) is when added to another medication for patients with focal onset seizures. The results showed that adding BRV helped many patients reduce the number of seizures, and some patients stopped having seizures completely. Side effects were generally mild.
Authors
- María José Aguilar-Amat
- Pedro Jesús Serrano-Castro (ORCID: https://orcid.org/0000-0002-3414-2707)
- Fernando Caballero‐Martínez (ORCID: https://orcid.org/0000-0001-7873-2824)
- Juan José Poza (ORCID: https://orcid.org/0000-0001-8610-1467)
- Francisco J. Campos‐Lucas (ORCID: https://orcid.org/0000-0002-2517-3384)
- Ariadna Gifreu (ORCID: https://orcid.org/0000-0002-3566-518X)
- Daniel Campos (ORCID: https://orcid.org/0000-0003-4795-5309)
- Alberto García
- Manuel Toledo‐Argany
- Irene Santamaría‐Rodríguez
Institutions
- Universidad Francisco de Vitoria (ES)
- Hospital Universitario La Paz (ES)
- Biogipuzkoa Health Research Institute (ES)
- Hospital Regional Universitario de Málaga (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitario Central de Asturias (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Epilepsia Open
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1002/epi4.70073
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidad Francisco de Vitoria